Naveen Bazaj

Naveen Bazaj has a diverse work experience in various companies and roles. Naveen started their career at Barclays Investment Bank and worked as an Investment Banker from 2008 to 2010. Naveen then joined RBC Capital Markets as an Investment Banker from 2010 to 2011. After that, they worked at Alvine Pharmaceuticals Inc as part of the Business Development and Strategy team from 2011 to 2013. Naveen then became the Director of Corporate and Strategic Development at Promontory Therapeutics from 2013 to 2016. Naveen then joined Alphabet Inc., where they were involved in Strategic Partnerships and Business Development at Verily Life Sciences from 2016 to 2018. Currently, they are the Head of Corporate Development at Alector.

Naveen Bazaj completed a Bachelor of Science (B.S.) degree in Biology at UCLA from 2003 to 2007. Afterward, they pursued a Master of Business Administration (MBA) degree at Columbia Business School from 2013 to 2014.